Delivery Order SPE2DR25D1104-SPE2DR26FL116
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,127.84 to AmerisourceBergen Drug Corp for Aprepitant 125 mg capsule unit dose packages (6 count) on February 3, 2026, with completion scheduled for February 4, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,498.37 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packages of five. The contract is a firm fixed price delivery order with an ultimate completion date of December 5, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Aprepitant 40 mg capsule unit dose packages in quantities of 5. This competitively awarded, non-set-aside contract carries a ceiling value of $10,195.38 and operates under firm fixed pricing terms, with an ultimate completion date of November 4, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on January 5, 2026, for the supply of Aprepitant 40 mg capsules in unit dose packages of 5 units. This is a firm fixed-price delivery order valued at $6,492.22, with an ultimate completion date of January 6, 2026. The work will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and was competitively awarded...
- The Defense Logistics Agency awarded a delivery order valued at $9,188.59 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg Capsule Unit Dose packages (5-count) with a firm fixed-price structure. The contract, awarded January 7, 2026, with an ultimate completion date of January 8, 2026, represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $4,373.58 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packaging. This is a firm fixed-price, competitively awarded contract with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania facility, with an ultimate completion date of February 4, 2026. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), is a major...
- The Defense Logistics Agency awarded a $3,486.81 delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Aprepitant 40 mg capsule unit dose packages in quantities of five. The contract, which is not set-aside, carries a firm fixed price structure and an ultimate completion date of January 21, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child...
- The Defense Logistics Agency awarded a $2,899.88 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Aprepitant 125 mg capsules in unit dose packaging (6-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 13, 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the parent company Cencora, Inc.'s...
- The Defense Logistics Agency awarded a delivery order valued at $9,618.63 to AmerisourceBergen Drug Corp for the supply of Aprepitant 80 mg capsules in unit-dose packaging. The contract, executed on November 10, 2025, with an ultimate completion date of November 12, 2025, utilizes a firm fixed price structure with no set-aside designation, indicating competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,505.27 to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsule unit dose packages (5 count). The contract, executed on December 17, 2025, with an ultimate completion date of December 18, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FL116Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsules in unit dose packages of five on February 3, 2026, with a ceiling value of $2,106.22 and completion date of February 4, 2026. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling delivery of a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to fulfill government requirements for pharmaceutical products across multiple therapeutic domains through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 2/2/26 |